142 results on '"Cidre-Aranaz, Florencia"'
Search Results
2. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling
3. ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
4. Glutaredoxin 3 (GLRX3) confers a fusion oncogene-dependent vulnerability to Ewing sarcoma
5. Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes.
6. Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma
7. Small round cell sarcomas
8. Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma
9. Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma
10. Somatic gene delivery for flexible in vivo modeling of high-risk sarcoma
11. Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
12. Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancer
13. Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
14. A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas
15. Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
16. Drug Screening by Resazurin Colorimetry in Ewing Sarcoma
17. Analysis of Migration and Invasion in Ewing Sarcoma
18. Tumor Growth Analysis of Ewing Sarcoma Cell Lines Using Subcutaneous Xenografts in Mice
19. Ewing Sarcoma-Specific (Re)expression Models
20. Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
21. Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
22. Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma
23. Ewing sarcoma
24. Chromosome 8 gain drives poor patient outcome via expression of 4E-BP1 in Ewing sarcoma
25. Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
26. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation
27. Abstract PR004: Fusion protein-driven IGF-IR signals deregulate hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3
28. Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1
29. Additional file 3 of Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma
30. Additional file 1 of Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma
31. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
32. Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma
33. Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
34. Abstract 2003: Oncogenic interplay of FUS-DDIT3 and YAP1 in myxoid liposarcoma
35. Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
36. Sarcoma treatment in the era of molecular medicine
37. Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
38. Systems biology analysis identifies TCF7L1 as a key regulator of metastasis in Ewing sarcoma
39. Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1
40. Sarcoma treatment in the era of molecular medicine
41. High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma
42. Integrative clinical transcriptome analysis revealsTMPRSS2‐ERGdependency of prognostic biomarkers in prostate adenocarcinoma
43. Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients
44. Oncogenic hijacking of a developmental transcription factor evokes therapeutic vulnerability for ROS-induction in Ewing sarcoma
45. Expression patterns of PD-L1 and PD-1 provide rationales for immune checkpoint inhibition in soft tissue sarcomas
46. Biomarker-based outcome prediction in prostate adenocarcinoma depends on theTMPRSS2-ERGstatus
47. Cooperation of dominant oncogenes with regulatory germline variants shapes clinical outcomes in childhood cancer
48. SOX2 expression identifies Ewing sarcoma patients with high risk for tumor relapse and poor survival
49. Targeting the CALCB/RAMP1-axis inhibits growth of Ewing sarcoma
50. Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.